Inrals

International Network of Recruitment Agencies in Life Sciences

Close

Search for:

Our story
Why INRALS?
Members
News
Blog
Knowledge Centre
- Shared expertise
- Downloads
Contact
Selected vacancies
Search for:

Menu

Keywords

Location

News

General Assembly Munich: INRALS switching up gears
November 6, 2018
The Weatherhills Group (USA) joins INRALS
September 10, 2018
INRALS welcomes Carpenova (Denmark/Sweden)
March 20, 2018

Twitter

#EHR vendor contracts may contain clauses that block information sharing on improving usability and patient safety research. spr.ly/6019EyElz pic.twitter.com/6zklfWnRe8

About 4 minutes ago from AMA's Twitter

Debbie is one of the 70% of adults 50-64 years of age with a chronic health condition, and the flu made her symptoms worse. Learn more about her story: bit.ly/2Bj4ACf #IGotMyShot #fightflu pic.twitter.com/zhUz2f3myU

About 10 minutes ago from Sanofi US's Twitter

Check out this message from @dak on why supporting #cancer research through #ReadyRaiseRise is personal for him. pic.twitter.com/zjmAMRzr9a

About 49 minutes ago from Bristol-Myers Squibb's Twitter

At 11:00 am ET today, join NIDA Director Dr. Nora Volkow for a Facebook Live to learn about recent findings and get answers to your questions on vaping. #ThisIsNIH pic.twitter.com/ukfNduIIVi

About 49 minutes ago from NIH's Twitter

Read how our colleagues in Germany play #Santa (#derWeihnachtsmann) and provide much needed holiday cheer to homeless and refugee children

About 49 minutes ago from Bristol-Myers Squibb's Twitter

Physicians, drug developers and payers can use #RealWorldData to help inform healthcare decisions.

About 49 minutes ago from Bristol-Myers Squibb's Twitter

To better capture what Harvard Medical School stands for as a school, as a research institution and as an organization committed to improving the human condition, we are introducing a new mission statement hvrd.me/6soY30mXTEm pic.twitter.com/j6ypKjnlrZ

About 49 minutes ago from Harvard Medical School's Twitter

Pharmalot.. Pharmalittle.. Good Morning.. Catalyst will charge $375K for its rare disease drug & more interesting news.. statnews.com/pharmalot/2018… #pharma $VRTX $CPRX $INSY $MNK $MRK $JNJ $NVS $SUNPHARMA $ALNY $IONS $BHC #vaccines #opioids

About an hour ago from pharmalot's Twitter

Up to 20% to 25% of clinical studies close because they fail to meet enrollment targets so selecting a site based on its enrollment capability is key to a successful #clinicaltrial pharmavoice.com/digital-editi… pic.twitter.com/Pun5VFbANt

About an hour ago from PharmaVOICE's Twitter

Mylan says US patent board invalidates formulation patents covering Sanofi's Lantus firstwordpharma.com/node/1611… $MYL $SNY

About an hour ago from FirstWord Pharma's Twitter

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome… goo.gl/fb/696h6E

About 2 hours ago from Pharma News's Twitter

Today’s #ThisIsNIH posts will introduce you to @NIDAnews’s leadership and some of our hardworking staff. drugabuse.gov pic.twitter.com/AV9oiigS7A

About 2 hours ago from NIH's Twitter

Isn't it so angels can exit out like this we often see some bizarre IPOs .. Moderna was perhaps the best money raising biotech in Cambridge in recent history, netting another $125M from Merck at an $18B valuation in May . They ra…lnkd.in/eCtVD8A lnkd.in/eahkR5R

About 2 hours ago from Pharma Connections's Twitter

The systems biology community celebrates the leadership of Marc Kirschner, founding chair of @HMS_SysBio hvrd.me/Rli230mSiGd

About 2 hours ago from Harvard Medical School's Twitter

What are neutrophils and what do they do? mnt.to/4LWT @mnt pic.twitter.com/JmxcPRtKTc

About 4 hours ago from Medical News Today's Twitter

Today’s Advisory Committee to the Director has a full schedule of topics ranging from addressing sexual harassment in science to the Next Gen Research Initiative. Tune in at 8:30amET for @NIHDirector’s report to start the day. See agenda & livestream: acd.od.nih.gov/meetings.html #NIH

About 4 hours ago from NIH's Twitter

Biogen scraps deal with AGTC to develop gene therapies for ophthalmic diseases firstwordpharma.com/node/1611… $BIIB $AGTC

About 4 hours ago from FirstWord Pharma's Twitter

Colorectal cancer: Loss of two genes may drive tumor formation mnt.to/4LWt @mnt #colon #cancer pic.twitter.com/e0iWN5POy8

About 5 hours ago from Medical News Today's Twitter

In Stalking Horse Bid, Bausch Health Buys Synergy Pharma’s Assets dlvr.it/QtVmwx pic.twitter.com/vgVskZaoom

About 9 hours ago from Pharmaceutical's Twitter

FDA Expands on Biologics and Biosimilars Action Plan, Especially for Diabetes Products dlvr.it/QtVmwM pic.twitter.com/YaUG4ttgzn

About 9 hours ago from Pharmaceutical's Twitter

Baby Gene Edits Could Affect a Range of Traits dlvr.it/QtVmkt pic.twitter.com/4IsL668F0R

About 9 hours ago from Pharmaceutical's Twitter

The synthetic stem cells market is expected to grow from USD 14 million in… goo.gl/fb/f2gqAR #news #pharma

About 10 hours ago from Pharma News's Twitter

Tocagen Announces Pricing of Public Offering of Common Stock goo.gl/fb/MDZ89x #news #pharma

About 10 hours ago from Pharma News's Twitter

Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal… goo.gl/fb/NmEiyD #news #pharma

About 10 hours ago from Pharma News's Twitter

2018 Emerging Immunohematology and NAT Technologies, Country Market Shares… goo.gl/fb/qcxWBw #news #pharma

About 10 hours ago from Pharma News's Twitter

Phospholipase Enzyme Market: Global Industry Analysis 2013-2017 and… goo.gl/fb/mpVYNx #news #pharma

About 10 hours ago from Pharma News's Twitter

Global pharmaceutical robots market is expected to grow with a CAGR of 13.2… goo.gl/fb/vEQQjC #news #pharma

About 10 hours ago from Pharma News's Twitter

Kratom Trade Association: Kratom Community Needs Less “Doomsday Rhetoric… goo.gl/fb/pD7okj #news #pharma

About 10 hours ago from Pharma News's Twitter

Tilray&#174; Announces International Advisory Board goo.gl/fb/oAguLv #news #pharma

About 10 hours ago from Pharma News's Twitter

#ngs #mergersandacquisitions lnkd.in/eMtCKwh

About 11 hours ago from Pharma Connections's Twitter

Contact

INRALS Office Management
(Derks & Derks)
Databankweg 12a
3821 AL Amersfoort
The Netherlands

T +31 33 472 80 87
E info@inrals.com
I www.derksenderks.nl

INRALS B.V.
KvK/CoC 60618604